Food News and Research

RSS

Savient second-quarter net loss decreases to $5.0 million

Savient Pharmaceuticals, Inc. reported financial results for the three and six months ended June 30, 2010. The net loss for the second quarter of 2010 was $5.0 million, or $0.07 per basic and diluted share, on total revenues of $1.0 million, compared with a net loss of $54.8 million, or $0.92 per basic and diluted share on total revenues of $0.7 million for the second quarter of 2009.

4 Aug 2010

Senate vote on Medicaid help for states delayed because of cost underestimate

Senate Democrats Monday delayed a scheduled vote on a provision to aid states and local governments after the Congressional Budget Office said the bill would increase spending. The CBO analysis further complicates efforts to extend enhanced federal Medicaid funding to states.

4 Aug 2010

Study shows link between fructose and pancreatic cancer proliferation

Pancreatic cancers use the sugar fructose, very common in the Western diet, to activate a key cellular pathway that drives cell division, helping the cancer to grow more quickly, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found.

4 Aug 2010

Senate Dems circulate new version of proposal to extend enhanced federal Medicaid payments

Tuesday morning, the Republican Policy Committee sent a memo "to staffers highlighting the major changes in the Senate bill that extends enhanced federal Medicaid funding to states for six months." On Monday, Senate Majority Leader Harry Reid tabled an earlier version of this measure after "it received a bad score from the Congressional Budget Office.

4 Aug 2010

Sensory dysfunction affects quality of life of patients with Autism

The way the brain reacts differently to the sense of touch in people with Autism will be examined as part of an innovative Cardiff University study designed to create better understanding of the condition. Dr David McGonigle from Cardiff University's Schools of Psychology and Biosciences will use the latest brain imaging techniques to create a clearer picture of how touch is processed differently.

4 Aug 2010

Celera decreases second-quarter net loss to $6.1 million

Celera Corporation today reported net revenues of $32.6 million for the second quarter of 2010 that ended June 26, 2010, compared to $41.4 million for the prior year quarter. For the second quarter of 2010, Celera reported a net loss of $6.1 million, or $0.07 per share, compared to a net loss of $31.7 million, or $0.39 per share, for the prior year quarter.

4 Aug 2010

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector.

4 Aug 2010

$CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL$

CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL

Cell Therapeutics, Inc. today announced it has filed for a Special Protocol Assessment ("SPA") with the U.S. Food and Drug Administration ("FDA") for the design of its new phase III trial of pixantrone for patients with relapsed or refractory aggressive B-Cell non-Hodgkin's lymphoma ("NHL").

4 Aug 2010

SVH launches Guiding Stars nutrition guidance program

The highly regarded Guiding Stars nutrition guidance program - now available in more than 1,500 grocery stores and schools - today announces its partnership with Sebasticook Valley Hospital (SVH) in Pittsfield, Maine to launch the nutrition guidance program in a hospital for the first time. Guiding Stars will rate prepared meals, snacks, and grab-and-go items according to their nutritional value in the hospital cafeteria. Each item rated will receive zero to three stars for an at-a-glance summary of the food's nutritional quality.

4 Aug 2010

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

4 Aug 2010

Arena reports lower net loss of $28.80M for second-quarter 2010

Arena Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010, and recent developments, including the successful Pre-Approval Inspection, or PAI, of the company's Swiss drug product manufacturing facility by the US Food and Drug Administration, or FDA.

4 Aug 2010

Asian ministers review MDGs progress

South Asia is "lagging behind" in poverty and hunger reduction and is "in danger" of missing key Millennium Development Goal (MDG) targets, a U.N. official told Asian ministers gathered to discuss MDGs progress, Agence France-Presse reports. At the meeting, "senior officials told delegates from dozens of countries that global food, energy and financial crises in recent years had jeopardized progress toward achieving the goals set for 2015," the news service writes.

4 Aug 2010

Bisphenol A may decrease sperm quality, concentration: Research

In one of the first human studies of its kind, researchers have found that urinary concentrations of the controversial chemical Bisphenol A, or BPA, may be related to decreased sperm quality and sperm concentration.However, the researchers are quick to point out that these results are preliminary and more study is needed. Several studies have documented adverse effects of BPA on semen in rodents, but none are known to have reported similar relationships in humans.

4 Aug 2010

Long-term dietary consumption of capsaicin can reduce blood pressure: Research

For those with high blood pressure, chili peppers might be just what the doctor ordered, according to a study reported in the August issue of Cell Metabolism, a Cell Press publication. While the active ingredient that gives the peppers their heat-a compound known as capsaicin-might set your mouth on fire, it also leads blood vessels to relax, the research in hypertensive rats shows.

4 Aug 2010

CSI launches Diamondback Predator 360 catheter system for treatment of peripheral arterial disease

Cardiovascular Systems, Inc. has launched its second-generation product, the Diamondback Predator 360° PAD System, for the treatment of peripheral arterial disease (PAD). The new device uses the same mechanism of action as the clinically proven Diamondback 360 PAD System with improvements in the crowns and shaft for enhanced clinical performance and shorter procedure times.

4 Aug 2010

Master model to track mercury movement from original emission source to humans

University of Louisville Public Health doctoral student Caroline Chan is working to create scientific tools to help environmental policy decision makers evaluate and modify mercury emission regulations.

3 Aug 2010

MAP Pharmaceuticals reports net loss of $12.5M for second-quarter 2010

MAP Pharmaceuticals, Inc. today announced financial results for the second quarter ended June 30, 2010.

3 Aug 2010

POZEN reports $16.2M net income for second-quarter 2010

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2010.

3 Aug 2010

Health and Safety Watch launches new website to help Canadians access health-related information

Health and Safety Watch Inc., an organization established to help Canadians manage all types of health and safety hazards, today officially launched www.HealthandSafetyWatch.com, a new website designed to give Canadians easy access to real-time information about the 500-plus product, food, and drug recalls, as well as health advisories, that occur every year.

3 Aug 2010

U.S. Department of Justice seeks permanent injunction against N.Y. food processor over listeria contamination

The U.S. Department of Justice, in an action initiated by the U.S. Food and Drug Administration, is seeking a permanent injunction against NY Gourmet Salads, Inc., a processor of ready-to-eat deli salads, seafood salads, and cream cheeses in Brooklyn, N.Y., and Leonard F. Spada, the company's president.

3 Aug 2010